Research programme: histone deacetylase inhibitors - MethylGene

Drug Profile

Research programme: histone deacetylase inhibitors - MethylGene

Alternative Names: MG 4230; MG 4915; MG 5026; Next generation inhibitors; Sirtuin inhibitors

Latest Information Update: 15 May 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MethylGene
  • Class Sirtuins; Small molecules
  • Mechanism of Action Histone deacetylase inhibitors; SIRT1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bacterial infections; Cancer; Diabetes mellitus; Inflammation

Most Recent Events

  • 30 Mar 2010 Preclinical development is ongoing in USA
  • 25 Mar 2008 Preclinical development is ongoing
  • 08 Mar 2008 Pharmion Corporation has been acquired and merged into Celgene Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top